Neue substituierte Alkandiphosphonsäuren
European patent · EP0275821 · Deleted
Register entry
- Publication number
- EP0275821
- Application number
- EP87810664
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Nov 16, 1987
- Published
- Jul 27, 1988
- Granted
- Feb 26, 1992
- Deleted
- Nov 15, 2007
- Reason
- Maximum term reached
- IPC classes
- C07F 9/547 (2006.01)A61K 31/675 (2006.01)
- Priority
- CH A 4666/86 21.11.1986
- Filing language
- German
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 14, 2007
Maximum term reached
Published in +pat+ No 23 in 2007
- Jan 31, 2003
Transferred
- Owner
- Novartis AG, Schwarzwaldallee 215, 4058 Basel → Novartis Pharma AG, Lichtstrasse 35, 4056 Basel
Published in +pat+ No 2 in 2003
- Feb 14, 1997
Address changed
- Owner
- CIBA-GEIGY AG, Klybeckstrasse 141, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel
Published in PIDTJ No 3 in 1997
- Apr 15, 1992
Granted
Published in PIDTJ No 7 in 1992
Parties
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.